Counterfeit drug sales doubled between 2005 and 2010, reaching $75 billion per year globally according to the International Journal of Clinical Practice. Counterfeit medicines are an increasing threat to public health and can erode consumer confidence in pharmaceutical therapy. Using our proprietary computer vision pill recognition technologies, MedSnap has developed MedSnap Verify Services to respond to this growing global crisis. Continue reading
MedSnap to Launch Verify Services in Basel, Switzerland, April 7-10, 2014
Leave a reply